Correlation Between Aileron Therapeutics and ALK Abell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and ALK Abell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and ALK Abell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aileron Therapeutics and ALK Abell AS, you can compare the effects of market volatilities on Aileron Therapeutics and ALK Abell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of ALK Abell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and ALK Abell.

Diversification Opportunities for Aileron Therapeutics and ALK Abell

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Aileron and ALK is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and ALK Abell AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALK Abell AS and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with ALK Abell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALK Abell AS has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and ALK Abell go up and down completely randomly.

Pair Corralation between Aileron Therapeutics and ALK Abell

If you would invest  2,205  in ALK Abell AS on September 20, 2024 and sell it today you would earn a total of  0.00  from holding ALK Abell AS or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Aileron Therapeutics  vs.  ALK Abell AS

 Performance 
       Timeline  
Aileron Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aileron Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
ALK Abell AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ALK Abell AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Aileron Therapeutics and ALK Abell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aileron Therapeutics and ALK Abell

The main advantage of trading using opposite Aileron Therapeutics and ALK Abell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, ALK Abell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALK Abell will offset losses from the drop in ALK Abell's long position.
Aileron Therapeutics vs. Bio Path Holdings
Aileron Therapeutics vs. Benitec Biopharma Ltd
Aileron Therapeutics vs. Artelo Biosciences
Aileron Therapeutics vs. Histogen
The idea behind Aileron Therapeutics and ALK Abell AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
ALK Abell vs. Defence Therapeutics
ALK Abell vs. Aileron Therapeutics
ALK Abell vs. Enlivex Therapeutics
ALK Abell vs. Living Cell Technologies
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY